Institutional investors purchased a net $1.7 million shares of OMER during the quarter ended June 2017, and now own 45.87% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 23.9 Thousand shares of Omeros Corp